FRANK C. MCGEEHIN III, MD

WYNNEWOOD, PA

Research Active
Internal Medicine - Interventional Cardiology NPI registered 21+ years 2 publications 2024 – 2024 NPI: 1598760340
StrokeRobotic Surgical ProceduresCoronary Artery DiseaseCoronary Artery BypassPercutaneous Coronary Intervention

Practice Location

100E LANCASTER AVE
WYNNEWOOD, PA 19096-3450

Phone: (484) 476-1000

What does FRANK MCGEEHIN research?

Dr. McGeehin studies the effectiveness and safety of robotic-assisted methods for heart surgeries, particularly for patients with blocked arteries. He primarily works on conditions related to coronary artery disease, where traditional bypass surgery may not be possible. His research shows how robotic techniques can lead to better surgical results and fewer complications, which is crucial for enhancing patients' quality of life during recovery.

Key findings

  • In a study of 285 patients undergoing reverse hybrid coronary revascularization, 10.9% died within about four years and 35.9% faced serious heart-related complications.
  • Over 16 years, a study involving 2,280 patients showed that the average surgery time for robotic-assisted coronary revascularization decreased from 6.4 hours to 5.5 hours.
  • The rate of complications and the necessity for repeat surgeries significantly reduced over time for patients undergoing robotic-assisted heart surgery.

Frequently asked questions

Does Dr. McGeehin study coronary artery disease?
Yes, Dr. McGeehin focuses on coronary artery disease and the surgical options available for patients with this condition.
What treatments has Dr. McGeehin researched?
He has researched robotic-assisted surgeries, specifically techniques like reverse hybrid coronary revascularization for patients with heart artery blockages.
Is Dr. McGeehin's work relevant to patients needing heart surgery?
Absolutely. His research offers valuable insights into safer surgical options for patients who cannot undergo traditional methods.

Publications in plain English

Long-term clinical outcomes of robotic-assisted surgical coronary artery revascularisation.

2024

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Dokollari A, Sicouri S, Erten O, Gray WA, Shapiro TA +12 more

Plain English
This study looked at the long-term results of robotic-assisted heart surgery for patients who weren't able to undergo traditional bypass surgery. It involved 2,280 patients over several years, and researchers found that as time went on, patients were older and surgery times got shorter (from an average of 6.4 hours to 5.5 hours). Importantly, the rates of serious complications and death decreased significantly over time, showing that this new method leads to better outcomes for patients. Who this helps: Patients with heart conditions who cannot have traditional surgery.

PubMed

Midterm Clinical Outcomes of Robotic-Assisted Reverse Hybrid Coronary Revascularization: A Single-Center Experience.

2024

The American journal of cardiology

Dokollari A, Gemelli M, Sicouri S, Gray WA, Shapiro TA +19 more

Plain English
This study looked at the results of a special heart surgery called robotic-assisted reverse hybrid coronary revascularization (HCR) in 285 patients over several years. They found that after an average of 4.2 years, 10.9% of patients had died from various causes, and 35.9% experienced serious heart or brain-related issues, although complications like strokes and reoperations were rare. This matters because it indicates that this surgery can be effective and safe for patients with complex heart blockages. Who this helps: Patients with multivessel coronary artery disease.

PubMed

Frequent Co-Authors

Aleksander Dokollari Serge Sicouri William A Gray Timothy A Shapiro Marwan Badri Paul Coady Eric Gnall Mara Caroline Amid A Khan Stephanie Kjelstrom

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.